Carl Zeiss Meditec AG's latest marketcap:
As of 08/02/2025, Carl Zeiss Meditec AG's market capitalization has reached $4.69 B. According to our data, Carl Zeiss Meditec AG is the 3473th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 4.69 B |
Revenue (ttm) | 2.51 B |
Net Income (ttm) | 180.57 M |
Shares Out | 87.54 M |
EPS (ttm) | 2.05 |
Forward PE | 21.41 |
Ex-Dividend Date | 03/27/2025 |
Earnings Date | 08/07/2025 |
Carl Zeiss Meditec AG's yearly market capitalization.
Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
---|---|---|---|---|
08/02/2025 | €4.05 B | $4.69 B | 1.63% | 3473 |
12/30/2024 | €3.98 B | $4.12 B | -54.93% | 3434 |
12/29/2023 | €8.84 B | $9.76 B | -16.17% | 1659 |
12/30/2022 | €10.55 B | $11.29 B | -36.22% | 1369 |
12/30/2021 | €16.53 B | $18.79 B | 69.74% | 1061 |
12/30/2020 | €9.74 B | $11.9 B | -4.22% | 1393 |
12/30/2019 | €10.17 B | $11.4 B | 66.47% | 1175 |
12/28/2018 | €6.11 B | $7 B | 31.96% | 1549 |
12/29/2017 | €4.63 B | $5.55 B | 62.67% | 2149 |
12/30/2016 | €2.85 B | $2.99 B | 22.59% | 2920 |
Company Profile
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG is a leading medical technology company based in Jena, Germany, with operations across Europe, North America, and Asia. Founded in 1846, it is a subsidiary of Carl Zeiss AG and specializes in innovative solutions for ophthalmology and microsurgery.
Business Segments
The company operates in two key segments:
-
Ophthalmology: Provides products and solutions for diagnosing and treating chronic eye diseases, including:
- Devices for general eye examinations (slit lamps, refractometers, tonometers)
- Optical coherence tomography (OCT) devices and fundus cameras
- Surgical equipment (microscopes, phacoemulsification, vitrectomy devices)
- Intraocular lenses and laser eye surgery systems
- Microsurgery: Offers solutions for invasive surgical treatments in ENT, plastic/reconstructive, neuro, dental, and spinal surgeries.
Customer Base
Carl Zeiss Meditec serves physicians and hospitals worldwide, delivering advanced medical technologies to improve patient care.
Frequently Asked Questions
-
What is Carl Zeiss Meditec AG's (ETR-AFX) current market cap?As of 08/02/2025, Carl Zeiss Meditec AG (including the parent company, if applicable) has an estimated market capitalization of $4.69 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Carl Zeiss Meditec AG (ETR-AFX) rank globally by market cap?Carl Zeiss Meditec AG global market capitalization ranking is approximately 3473 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.